Antibiotics medicine for injection

A technology for antibiotics and injections, applied in the direction of antibacterial drugs, pharmaceutical formulas, medical preparations containing active ingredients, etc., to achieve widespread application, strong antibacterial activity, and good curative effect

Inactive Publication Date: 2003-07-30
REYOUNG PHARMA
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it is almost ineffective against infections caused by enzyme-producing bacteri

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0012] The present invention will be further described below in conjunction with embodiment.

[0013] For the antibiotic drug for injection according to the present invention, the proportions by weight of mezlocillin sodium and sulbactam sodium that we have tested are respectively: 1: 1, 2: 1, 2.5: 1, 3: 1, 3.5: 1, 4: 1, 4.5: 1, 5: 1, 6: 1, 8: 1, 10: 1, 12: 1, 14: 1, 16: 1, respectively to obtain different degrees of enhancement effect, with 4: 1 ratio The effect is most pronounced.

[0014] Preparation method: wash the molded antibiotic bottle and butyl rubber stopper, dry and sterilize it, and set it aside. The mezlocillin sodium and the sulbactam sodium are mixed evenly in proportion respectively in a mixer, and measured and packaged to obtain the finished medicine of the present invention.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to medicine technology and is improved mezlocillin sodium injection. The injection has one medicine weight ratio of mezlocillin sodium/Sulbactam sodium 1-16 to 1. It hasstrong antibacterial activity, wide antibacterial spectrum and thus high curative effect, and may be used in treating serious urinary tract infection, respiratory tract infection, intestinal tract, otorbinolaryngological infection, abdominal cavity infection, etc. caused by zymogenic staphylococcus, pneumococcus, enterococcus, purulent streptococcus, Hemophilus infuenzae, etc.

Description

technical field [0001] The invention relates to an antibiotic medicine for injection, belonging to the technical field of medicine and medicine. Background technique [0002] Antibiotic drugs are a large class of drugs with a wide range of applications, and antibiotic drugs for injection are a large category of antibiotic drugs. At present, the clinically used mezlocillin sodium for injection has a good curative effect and is widely used to prevent respiratory infections caused by sensitive bacteria in Gram-negative bacilli such as Escherichia coli, Enterobacter, and Proteus. systemic, urinary, digestive, gynecological and reproductive infections. For sepsis, suppurative meningitis, peritonitis, osteomyelitis, skin and soft tissue infection, ophthalmology and ear, nose, throat infection have good curative effect. However, it is almost ineffective against infections caused by enzyme-producing bacteria, and its antibacterial activity and antibact...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/429A61P31/04
Inventor 赵玉山苗得足崔维初李广
Owner REYOUNG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products